Stent Platform
*Fully degradable poly(L-lactide)
*Sine wave structure in space, In-phase peak-valley connection
Drug coating
*Fully degradable poly(D,L-lactide)
*Effectively control the sirolimus release rate
Drug
*Classical Sirolimus with dose of 15.3ug/mm
*Inhibit the proliferation and migration of smooth muscle cells
Delivery system
*Completely self-developed second-generation rapid-exchange balloon dilatation catheter
*Superior pushability and crossability